Article content

LONDON — GlaxoSmithKline and Google parent Alphabet’s life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a novel field of medicine called bioelectronics.

Verily Life Sciences — known as Google’s life sciences unit until last year — and Britain’s biggest drugmaker will together contribute 540 million pounds (US$715 million) over seven years to Galvani Bioelectronics, they said on Monday.

We apologize, but this video has failed to load.

tap here to see other videos from our team. Try refreshing your browser, or Google parent Alphabet and U.K. pharmaceutical firm to create company focused on fighting diseases Back to video

The new company, owned 55 per cent by GSK and 45 per cent by Verily, will be based at GSK’s Stevenage research centre north of London, with a second research hub in South San Francisco.

It is GSK’s second notable investment in Britain since the country voted to leave the European Union in June. Last week it announced plans to spend 275 million pounds on drug manufacturing.